EDRH
NVCT icon

Edmond de Rothschild Holding’s Nuvectis Pharma NVCT Stock Holding History

Edmond de Rothschild Holding’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Hold
15,170
– – ﹤0.01% 406
2025
Q4 		$115K Hold
15,170
– – ﹤0.01% 420
2025
Q3 		$91.3K Hold
15,170
– – ﹤0.01% 434
2025
Q2 		$113K Hold
15,170
– – ﹤0.01% 409
2025
Q1 		$148K Hold
15,170
– – ﹤0.01% 402
2024
Q4 		$82.1K Sell
15,170
-4,000
-21% -$25.1K ﹤0.01% 464
2024
Q3 		$121K Hold
19,170
– – ﹤0.01% 458
2024
Q2 		$121K Hold
19,170
– – ﹤0.01% 471
2024
Q1 		$157K Hold
19,170
– – ﹤0.01% 447
2023
Q4 		$160K Buy
+19,170
New +$171K ﹤0.01% 454
2023
Q3 		– Sell
-22,820
Closed -$364K – 738
2023
Q2 		$364K Sell
22,820
-1,750
-7% -$27.9K 0.01% 400
2023
Q1 		$322K Buy
+24,570
New +$249K 0.01% 399

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Edmond de Rothschild Holding's NVCT Position: Q1 2026 in Review

Edmond de Rothschild Holding held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 15,170 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Edmond de Rothschild Holding first reported a position in NVCT in Q1 2023 and has held it in 12 quarters since. The position peaked at $364K in Q2 2023. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Edmond de Rothschild Holding held 15,170 shares of Nuvectis Pharma worth $117K as of Q1 2026.
  • Edmond de Rothschild Holding left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #406 holding.
  • Edmond de Rothschild Holding first reported a position in Nuvectis Pharma in Q1 2023 and has held it in 12 quarters since.
  • Edmond de Rothschild Holding's Nuvectis Pharma position peaked at $364K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.